Correction  by unknown
CORRECTION
For the article titled “A personal experience with the influence of diabetes and other factors on the outcome of
infrainguinal bypass grafts for occlusive disease” (J Vasc Surg 2007;46:271-9), Tables 1 – 6 were published online but
omitted from the printed article. They are produced below.





P-valueNo. % No. %
Operations 312 48 338 52
Insulin-dependent diabetes 195 62 NA NA
Men 195 62 217 64 .65
Women 117 38 121 36
Age (y) .62
59 or younger 85 27 83 25
60 to 69 111 36 118 35
70 or older 116 37 137 40
Preoperative symptoms
Claudication only 27 8.7 70 21 .001
Rest pain 92 29 140 41 .002
Cutaneous ulceration 81 26 71 21 .14
Gangrene 108 35 45 13 .001
Distal emboli 4 1.3 12 3.6 .062
Overall classification .001
Claudication only 27 8.7 70 21
Critical ischemia 285 91 268 79
Serum creatinine (mg/dL) .003
1.5 or lower 225 72 286 85
1.6 to 1.9 42 13 26 7.7
2.0 or higher 20 6.4 11 3.3
Dialysis 21 6.7 7 2.1
Data unavailable 4 1.3 8 2.4
Prior CABG or PTCA 81 26 61 18 .015
Incidental 79 25 49 14 .001
Planned preliminary 2 0.6 12 3.6
Severe clinical COPD 8 2.6 12 3.6 .47
Previous ipsilateral procedures 106 34 160 47 .001
Inflow operations 25 8.0 65 19 .001
Infrainguinal bypass 39 12 80 24 .001
Femoral endarterectomy or profundaplasty 6 1.9 16 4.7 .048
Lumbar sympathectomy 13 4.2 11 3.3 .54
Balloon angioplasty 9 2.9 5 1.5 .22
Minor amputations or other 17 5.4 4 1.2 .002
Major contralateral amputation 35 11 26 7.7 .12
Below-knee 23 7.4 13 3.8 .22
Above-knee 12 3.8 13 3.8
NA, Not applicable; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; COPD, chronic obstructive
pulmonary disease
*Includes 12 operations in 11 patients whose diabetic status is unknown















Autogenous grafts 389 17 116 29 62 78 79 27
In situ saphenous vein 163 3 40 14 24 39 35 16
Reversed saphenous vein 165 14 65 11 28 29 19 7
Non-reversed saphenous vein 13 0 0 0 1 2 7 3
Arm vein 34 0 7 4 5 8 11 1
Spliced vein 14 0 4 0 4 0 7 0
Synthetic grafts 261 98 101 16 27 20 21 1
Ringed PTFE 78 28 26 6 11 4 5 0
Non-ringed PTFE 139 64 57 6 5 7 5 0
Composite PTFE/vein 39 5 16 3 10 9 11 1
Other 5 1 2 1 1 0 0 0
Total 650* 115 217 45 89 98 100 28
AK, Above-knee; BK, below-knee; PTFE, polytetrafluorethylene
*Includes 41 grafts with multiple (n83) outflow target vessels828
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No diabetes (reference set) 1.0
Noninsulin-dependent 1.8 (0.65, 5.2) .25
Insulin-dependent 2.0 (0.83, 4.9) .12
Serum creatinine (mg/dL) .001
1.5 or lower (reference set) 1.0
1.6 to 1.9 2.1 (0.65, 6.5) .22
2.0 or higher 8.1 (2.8, 24) .001
Dialysis 6.6 (2.2, 20) .001
Outflow target vessel(s) .05
Above-knee popliteal (reference set) 1.0
Below-knee popliteal 9.2 (1.2, 72) .035
Tibial or peroneal 4.2 (0.53, 34) .17
Multiple vessels 2.0 (0.12, 35) .63
Graft thrombosis†
Diabetes mellitus .18
No diabetes (reference set) 1.0
Noninsulin-dependent 0.48 (0.22, 1.0) .067
Insulin-dependent 0.97 (0.54, 1.6) .81
Prior CABG or PTCA .026
No (reference set) 1.0
Yes 0.44 (0.21, 0.91)
Previous ipsilateral infrainguinal bypass .001
No (reference set) 1.0
Yes 2.4 (1.4, 4.1)
Major amputation‡
Diabetes mellitus .008
No diabetes (reference set) 1.0
Noninsulin-dependent 0.96 (0.37, 2.5) .93
Insulin-dependent 2.6 (1.4, 4.8) .004
Prior CABG or PTCA .030
No (reference set) 1.0
Yes 0.35 (0.13, 0.90)
CABG, Coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty
*Model also considered gender, age, preoperative symptoms (claudication only vs. critical ischemia) and previous ipsilateral infrainguinal bypass.
†Model also considered gender, age, outflow target vessel(s) and year of operation.
‡Model also considered age and outflow target vessel(s).
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No diabetes (reference set) 1.0
Noninsulin-dependent 1.4 (1.1, 1.8) .015
Insulin-dependent 1.5 (1.2, 1.8) .001
Age (y) .001
59 or younger (reference set) 1.0
60 to 69 1.3 (1.0, 1.8) .033
70 or older 2.1 (1.6, 2.8) .001
Preoperative symptoms .001
Claudication only (reference set) 1.0
Critical ischemia 2.2 (1.6, 3.1)
Serum creatinine (mg/dL) .001
1.5 or lower (reference set) 1.0
1.6 to 1.9 1.6 (1.2, 2.1) .004
2.0 or higher 2.7 (1.8, 4.1) .001
Dialysis 4.2 (2.7, 6.6) .001
Severe clinical COPD .026
No (reference set) 1.0
Yes 1.9 (1.1, 3.3)
Previous ipsilateral infrainguinal bypass .005
No (reference set) 1.0
Yes 0.67 (0.51, 0.89)
Loss of primary patency†
Diabetes mellitus .14
No diabetes (reference set) 1.0
Noninsulin-dependent 0.69 (0.48, 0.99) .046
Insulin-dependent 0.92 (0.69, 1.2) .55
Age (y) .029
59 or younger (reference set) 1.0
60 to 69 0.78 (0.59, 1.0) .093
70 or older 0.65 (0.48, 0.90) .009
Graft material .001
All-autogenous vein (reference set) 1.0
Synthetic or composite 1.7 (1.3, 2.2)
Outflow target vessel(s) .014
Above-knee popliteal (reference set) 1.0
Below-knee popliteal 2.0 (1.3, 3.0) .003
Tibial or peroneal 2.0 (1.3, 3.1) .002
Multiple vessels 2.0 (1.1, 3.6) .023
Previous ipsilateral infrainguinal procedure .002
No (reference set) 1.0
Yes 1.6 (1.2, 2.1)
Year of operation .036
1976 to 1980 (reference set) 1.0
1981 to 1985 0.72 (0.51, 1.0) .067
1986 to 1990 0.58 (0.38, 0.87) .009
1991 to 1995 0.85 (0.58, 1.2) .41
1996 to 2002 0.59 (0.39, 0.89) .012
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No diabetes (reference set) 1.0
Noninsulin-dependent 0.80 (0.49, 1.3) .38
Insulin-dependent 1.5 (1.0, 2.1) .026
Preoperative symptoms .001
Claudication only (reference set) 1.0
Critical ischemia 6.6 (2.7, 16)
Serum creatinine (mg/dL) .005
1.5 or lower (reference set) 1.0
1.6 to 1.9 0.51 (0.25, 1.0) .067
2.0 or higher 0.51 (0.16, 0.25) .25
Dialysis 2.4 (1.3, 4.5) .007
Graft material .045
All-autogenous vein (reference set) 1.0
Synthetic or composite 1.4 (1.0, 1.9)
COPD, Chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty
*Model also considered year of operation.
†Model also included preoperative symptoms (claudication only vs. critical ischemia), prior CABG or PTCA and severe clinical COPD.
‡Model also considered year of operation.

























13 9020 7917 7917 NA 0.30 (0.08, 1.2) .088
In situ GSV 153 747 698 5016 4220 0.65 (0.44, 0.96) .029
Arm vein 32 6017 3020 3020 3020 1.3 (0.82, 2.1) .27
Spliced vein 13 5019 5019 NA NA 1.5 (0.55, 3.9) .44
Popliteal Reversed GSV 62 6712 5813 5216 5216 1.0 .84
In situ GSV 40 6415 6415 NA NA 0.94 (0.49, 1.8)
Crural Reversed GSV 83 6412 4514 2817 2817 1.0 .011











13 1000 1000 1000 NA 0.00 (0.00, 0.00) .001
In situ GSV 153 836 807 5917 5121 0.55 (0.36, 0.85) .007
Arm vein 32 7017 5420 5420 5420 0.99 (0.55, 1.8) .97
Spliced vein 13 5019 5019 NA NA 1.6 (0.67, 4.0) .28
Popliteal Reversed GSV 62 6912 6215 5517 5517 1.0 .49
In situ GSV 40 7315 7315 NA NA 0.78 (0.38, 1.6)
Crural Reversed GSV 83 7410 6013 3521 3521 1.0 .007











13 1000 1000 1000 NA 0.00 (0.00, 0.00) .001
In situ GSV 153 925 867 6418 5622 0.39 (0.24, 0.64) .001
Arm vein 32 7715 6620 6620 6620 0.77 (0.37, 1.6) .48
Spliced vein 13 4630 4630 NA NA 1.9 (0.74, 4.9) .18
Popliteal Reversed GSV 62 7312 6614 6614 6614 1.0 .16
In situ GSV 40 8811 7816 5825 5825 0.55 (0.24, 1.3)
Crural Reversed GSV 83 7610 6113 3820 3820 1.0 .001
In situ GSV 113 935 887 6611 5624 0.34 (0.18, 0.62)
GSV: Greater saphenous vein
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Occluded Graft Major Amputation
n % P-value* n % P-value*
Total 650 176 27 NA 154 24 NA
Gender .083 .061
Men 412 101 25 88 21
Women 238 75 32 66 28
Age (y) .27 .008
50 or younger 56 16 29 17 30
51 to 64 235 79 34 73 31
65 to 74 224 54 24 38 17
75 or older 135 27 20 26 19
Diabetic classification .14 .006
No diabetes† 338 104 31 73 22
Noninsulin-dependent 117 24 21 20 17
Insulin-dependent 195 48 25 61 31
Original symptoms .098 .001
Claudication only 97 22 23 6 6.2
Critical ischemia 553 154 28 148 27
Previous ipsilateral bypass .001 .018
No 531 121 23 115 22
Yes 119 55 46 39 33
Postoperative graft thrombosis .002 .058
No 569 122 21 111 20
Patency restored by reoperation 46 20 43 15 33
Graft revisions .001 .001
None 465 98 21 85 18
1 126 44 35 36 29
2 42 23 55 21 50
3 or more 17 11 65 12 71
NA: Not applicable
*Generalized estimating equation model
†Includes 12 operations in 11 patients whose diabetic status is unknown
